Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2011, Article ID 687624, 17 pages
http://dx.doi.org/10.1155/2011/687624
Review Article

The ECG Vertigo in Diabetes and Cardiac Autonomic Neuropathy

1Department of Propaedeutic and Internal Medicine, Athens University Medical School, Laiko General Hospital, 17 Saint Thomas Street, Athens 11527, Greece
2Department of Cardiology, Athens University Medical School, Hippokration Hospital, 114 Vasilissis Sofias Avenue, Athens 11527, Greece

Received 23 December 2010; Accepted 2 March 2011

Academic Editor: Alexander Kokkinos

Copyright © 2011 Christina Voulgari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Schnell, W. Otter, and E. Standl, “The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice,” Diabetes care, vol. 32, supplement 2, pp. S326–S330, 2009. View at Google Scholar · View at Scopus
  2. S. Van Dieren, J. W. J. Beulens, Y. T. Van Der Schouw, D. E. Grobbee, and B. Neal, “The global burden of diabetes and its complications: an emerging pandemic,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 17, supplement 1, pp. S3–S8, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. C. Voulgari, D. Papadogiannis, and N. Tentolouris, “Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies,” Vascular Health and Risk Management, vol. 6, pp. 883–903, 2010. View at Google Scholar
  4. S. Boudina and E. D. Abel, “Diabetic cardiomyopathy revisited,” Circulation, vol. 115, no. 25, pp. 3213–3223, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. Theosophy, “Ancient landmarks: plato and aristotle,” Theosophy, vol. 27, no. 11, pp. 483–491, 1939. View at Google Scholar
  6. S. Zoungas and A. Patel, “Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies,” Annals of the New York Academy of Sciences, vol. 1212, no. 1, pp. 29–40, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. T. D. Miller, R. F. Redberg, and F. J. T. Wackers, “Screening asymptomatic diabetic patients for coronary artery disease: why not?” Journal of the American College of Cardiology, vol. 48, no. 4, pp. 761–764, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. G. A. Beller, “Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective?” Journal of the American College of Cardiology, vol. 49, no. 19, pp. 1918–1923, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. P. Poirier, J.-P. Després, and O. F. Bertrand, “Identifying which patients with diabetes should be tested for the presence of coronary artery disease—the importance of baseline electrocardiogram and exercise testing,” Canadian Journal of Cardiology, vol. 22, supplement A, pp. 9A–15A, 2006. View at Google Scholar
  10. A. Aneja, W. H. W. Tang, S. Bansilal, M. J. Garcia, and M. E. Farkouh, “Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options,” American Journal of Medicine, vol. 121, no. 9, pp. 748–757, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. Raev, “Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients,” Diabetes Care, vol. 17, no. 7, pp. 633–639, 1994. View at Google Scholar · View at Scopus
  12. C. M. Schannwell, M. Schneppenheim, S. Perings, G. Plehn, and B. E. Strauer, “Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy,” Cardiology, vol. 98, no. 1-2, pp. 33–39, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. T. H. Kim, S. H. Yu, S. H. Choi et al., “Pericardial fat amount is an independent risk factor of coronary artery stenosis assessed by multidetector-row computed tomography: the Korean Atherosclerosis Study 2,” Obesity (Silver Spring), vol. 19, no. 5, pp. 1028–1034, 2011. View at Google Scholar
  14. M. J. Babcock, E. Z. Soliman, J. Ding, R. A. Kronmal, and D. C. Goff Jr., “Pericardial fat and atrial conduction abnormalities in the Multiethnic Study of atherosclerosis (MESA),” Obesity (Silver Spring), vol. 19, no. 1, pp. 179–184, 2011. View at Google Scholar
  15. M. A. Gómez-Marcos, J. I. Recio-Rodríguez, E. Rodríguez-Snchez et al., “Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol,” BMC Public Health, vol. 10, Article ID 143, 2010. View at Publisher · View at Google Scholar · View at PubMed
  16. B. P. Wiik, A. C. K. Larstorp, A. Høieggen et al., “Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: the LIFE Study,” American Journal of Hypertension, vol. 23, no. 8, pp. 845–851, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. V. Barrios, C. Escobar, A. Calderón, R. Echarri, S. Barrios, and J. Navarro-Cid, “Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 10, no. 3, pp. 168–173, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. P. M. Okin, R. B. Devereux, M. S. Nieminen et al., “Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study,” Journal of the American College of Cardiology, vol. 38, no. 2, pp. 514–520, 2001. View at Publisher · View at Google Scholar
  19. T. N. James, “The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction: significance for understanding its pathogenesis, clinical course, diagnosis and prognosis,” Coronary Artery Disease, vol. 9, no. 5, pp. 291–307, 1998. View at Google Scholar · View at Scopus
  20. J. A. Beckman, P. Libby, and M. A. Creager, “Diabetes mellitus, the metabolic syndrome, and atherosclerotic vascular disease,” in Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, P. Libby, R. O. Bonow, D. L. Mann, and D. P. Zipes, Eds., pp. 1094–1105, Saunders Elsevier, Philadelphia, Pa, USA, 8th edition, 2008. View at Google Scholar
  21. M. Dweck, I. W. Campbell, D. Miller, and C. M. Francis, “Clinical aspects of silent myocardial ischaemia: with particular reference to diabetes mellitus,” British Journal of Diabetes and Vascular Disease, vol. 9, no. 3, pp. 110–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Cosson, J. R. Attali, and P. Valensi, “Markers for silent myocardial ischemia in diabetes. Are they helpful?” Diabetes and Metabolism, vol. 31, no. 2, pp. 205–213, 2005. View at Google Scholar · View at Scopus
  23. A. Avignon, A. Sultan, C. Piot et al., “Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients,” Diabetes Care, vol. 30, no. 11, pp. 2934–2939, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. T. M. E. Davis, P. Fortun, J. Mulder, W. A. Davis, and D. G. Bruce, “Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study,” Diabetologia, vol. 47, no. 3, pp. 395–399, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. F. J. Wackers, L. H. Young, S. E. Inzucchi et al., “Detection of ischemia in asymptomatic diabetics (DIAD) investigators: detection of silent myocardial ischemia in asymptomatic diabetic subjects,” Diabetes Care, vol. 27, no. 8, pp. 1954–1961, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Kumar, R. J. Prineas, A. M. Arnold et al., “Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults cardiovascular health study,” Circulation, vol. 118, no. 25, pp. 2790–2796, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. P. K. Stein, D. Sanghavi, P. P. Domitrovich, R. A. Mackey, and P. Deedwania, “Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study,” Journal of Cardiovascular Electrophysiology, vol. 19, no. 10, pp. 1037–1042, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. D. Aguilar, S. Z. Goldhaber, D. J. Gans et al., “Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy,” American Journal of Cardiology, vol. 94, no. 3, pp. 337–339, 2004. View at Publisher · View at Google Scholar · View at PubMed
  29. C. Pappone and V. Santlnelli, “Cardiac electrophysiology in diabetes,” Minerva Cardioangiologica, vol. 58, no. 2, pp. 269–276, 2010. View at Google Scholar
  30. D. Lloyd-Jones, R. J. Adams, T. M. Brown et al., “American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics—2010 update: a report from the American Heart Association,” Circulation, vol. 121, no. 7, pp. e46–e215, 2010. View at Google Scholar
  31. J. Shirani and V. Dilsizian, “Screening asymptomatic patients with type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome?” Current Cardiology Reports, vol. 12, no. 2, pp. 140–146, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. S. Bacci, M. Villella, A. Villella et al., “Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test,” European Journal of Endocrinology, vol. 147, no. 5, pp. 649–654, 2002. View at Google Scholar · View at Scopus
  33. E. Cosson, F. Paycha, J. Pares et al., “Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintography,” Diabetic Medicine, vol. 21, pp. 342–348, 2004. View at Google Scholar
  34. P. Valensi and E. Cosson, “It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia,” Diabetes and Metabolism, vol. 36, no. 2, pp. 91–96, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. G. W. Lyerly, X. Sui, T. S. Church, C. J. Lavie, G. A. Hand, and S. N. Blair, “Maximal exercise electrocardiography responses and coronary heart disease mortality among men with diabetes mellitus,” Circulation, vol. 117, no. 21, pp. 2734–2742, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. T. H. Marwick, M. D. Hordern, T. Miller et al., “Exercise training for type 2 diabetes mellitus: Impact on cardiovascular risk: a scientific statement from the american heart association,” Circulation, vol. 119, no. 25, pp. 3244–3262, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. F. J. Wackers, D. A. Chyun, L. H. Young et al., “Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the detection of ischemia in asymptomatic diabetics (DIAD) study,” Diabetes Care, vol. 30, no. 11, pp. 2892–2898, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. L. H. Young, F. J. Wackers, D. A. Chyun et al., “Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial,” Journal of the American Medical Association, vol. 301, no. 15, pp. 1547–1555, 2009. View at Google Scholar
  39. C. R. L. Cardoso, G. F. Salles, and W. Deccache, “Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study,” Journal of Diabetes and Its Complications, vol. 17, no. 4, pp. 169–178, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. P. T. Sawicki, S. Kiwitt, R. Bender, and M. Berger, “The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus,” Journal of Internal Medicine, vol. 243, no. 1, pp. 49–56, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. P. M. Okin, R. B. Devereux, E. T. Lee, J. M. Galloway, and B. V. Howard, “Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study,” Diabetes, vol. 53, no. 2, pp. 434–440, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. M. R. Nelson, K. R. Daniel, J. J. Carr et al., “Associations between electrocardiographic interval durations and coronary artery calcium scores: the Diabetes Heart Study,” Pacing and Clinical Electrophysiology, vol. 31, no. 3, pp. 314–321, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. D. Žďárská, P. Pelíšková, J. Charvát et al., “ECG body surface mapping (BSM) in type 1 diabetic patients,” Physiological Research, vol. 56, no. 4, pp. 403–410, 2007. View at Google Scholar · View at Scopus
  44. T. F. Christensen, L. Tarnow, J. Randløv et al., “QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correction,” Diabetologia, vol. 53, no. 9, pp. 2036–2041, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. T. Kubiak, A. Wittig, C. Koll et al., “Continuous glucose monitoring reveals associations of glucose levels with QT interval length,” Diabetes Technology and Therapeutics, vol. 12, no. 4, pp. 283–286, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. S. Giunti, G. Bruno, E. Lillaz et al., “Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB prospective complications study,” Diabetes Care, vol. 30, no. 8, pp. 2057–2063, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. C. Stettler, A. Bearth, S. Allemann et al., “QT interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up,” Diabetologia, vol. 50, no. 1, pp. 186–194, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. P. Rossing, L. Breum, A. Major-Pedersen et al., “Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus,” Diabetic Medicine, vol. 18, no. 3, pp. 199–205, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. H. J. van der Linde, B. Van Deuren, Y. Somers, B. Loenders, R. Towart, and D. J. Gallacher, “The Electro-Mechanical window: a risk marker for Torsade de Pointes in a canine model of drug induced arrhythmias,” British Journal of Pharmacology, vol. 161, no. 7, pp. 1444–1454, 2010. View at Google Scholar
  50. S. Giunti, G. Bruno, M. Veglio et al., “Electrocardiographic left ventricular hypertrophy in type 1 diabetes,” Diabetes Care, vol. 28, no. 9, pp. 2255–2257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. P. M. Okin, R. B. Devereux, K. E. Harris et al., “In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the losartan intervention for endpoint reduction in hypertension (LIFE) study,” Hypertension, vol. 50, no. 5, pp. 984–990, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. A. B. Lehtinen, K. R. Daniel, S. A. Shah et al., “Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the diabetes heart study,” Annals of Noninvasive Electrocardiology, vol. 14, no. 1, pp. 72–79, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. B. H. Van Huysduynen, C. A. Swenne, H. H. M. Draisma et al., “Validation of ECG indices of ventricular repolarization heterogeneity: a computer simulation study,” Journal of Cardiovascular Electrophysiology, vol. 16, no. 10, pp. 1097–1103, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. B. H. van Huysduynen, C. A. Swenne, J. J. Bax et al., “Dispersion of repolarization in cardiac resynchronization therapy,” Heart Rhythm, vol. 2, no. 12, pp. 1286–1293, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. C. Voulgari and N. Tentolouris, “Assessment of the spatial QRS-T angle by vectorcardiography: current data and perspectives,” Current Cardiology Reviews, vol. 5, no. 4, pp. 251–262, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. I. Kardys, J. A. Kors, I. M. Van der Meer, A. Hofman, D. A. M. Van der Kuip, and J. C. M. Witteman, “Spatial QRS-T angle predicts cardiac death in a general population,” European Heart Journal, vol. 24, no. 14, pp. 1357–1364, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. P. M. Rautaharju, C. Kooperberg, J. C. Larson, and A. LaCroix, “Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the women's health initiative,” Circulation, vol. 113, no. 4, pp. 473–480, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. C. H. Voulgari, N. Tentolouris, I. Moyssakis et al., “Spatial QRS-T angle: association with diabetes and left ventricular performance,” European Journal of Clinical Investigation, vol. 36, no. 9, pp. 608–613, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. M. L. Koivikko, M. Karsikas, P. I. Salmela et al., “Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes,” Diabetologia, vol. 51, no. 3, pp. 426–435, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. A. I. Vinik and D. Ziegler, “Diabetic cardiovascular autonomic neuropathy,” Circulation, vol. 115, no. 3, pp. 387–397, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. C. M. Licht, S. A. Vreeburg, A. K. van Reedt Dortland et al., “Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities,” The Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 5, pp. 2458–2466, 2010. View at Google Scholar · View at Scopus
  62. R. E. Maser, B. D. Mitchell, A. I. Vinik, and R. Freeman, “The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes a meta-analysis,” Diabetes Care, vol. 26, no. 6, pp. 1895–1901, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Tesfaye, A. J. M. Boulton, P. J. Dyck et al., “Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments,” Diabetes Care, vol. 33, no. 10, pp. 2285–2293, 2010. View at Publisher · View at Google Scholar · View at PubMed
  64. R. Pop-Busui, G. W. Evans, H. C. Gerstein et al., “Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial,” Diabetes Care, vol. 33, no. 7, pp. 1578–1584, 2010. View at Google Scholar
  65. J. Calles-Escandón, L. C. Lovato, D. G. Simons-Morton et al., “Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the action to control cardiovascular risk in diabetes (ACCORD) trial,” Diabetes Care, vol. 33, no. 4, pp. 721–727, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. D. Ziegler, W. Rathmann, C. Meisinger, T. Dickhaus, and A. Mielck, “Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry,” European Journal of Pain, vol. 13, no. 6, pp. 582–587, 2009. View at Publisher · View at Google Scholar · View at PubMed
  67. R. A. Gandhi, J. L. B. Marques, D. Selvarajah, C. J. Emery, and S. Tesfaye, “Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy,” Diabetes Care, vol. 33, no. 7, pp. 1585–1590, 2010. View at Publisher · View at Google Scholar · View at PubMed
  68. R. Pop-Busui, “Cardiac autonomic neuropathy in diabetes: a clinical perspective,” Diabetes Care, vol. 33, no. 2, pp. 434–441, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. N. Tentolouris, C. Voulgari, S. Liatis et al., “Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes,” Diabetes Care, vol. 33, no. 5, pp. 1112–1114, 2010. View at Publisher · View at Google Scholar · View at PubMed
  70. S. Liatis, K. Marinou, N. Tentolouris, S. Pagoni, and N. Katsilambros, “Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus,” Diabetic Medicine, vol. 24, no. 12, pp. 1375–1380, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. J. Elliott, S. Tesfaye, N. Chaturvedi et al., “Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors,” Diabetes Care, vol. 32, no. 10, pp. 1896–1900, 2009. View at Publisher · View at Google Scholar · View at PubMed
  72. S. S. Soedamah-Muthu, N. Chaturvedi, D. R. Witte et al., “Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS),” Diabetes Care, vol. 31, no. 7, pp. 1360–1366, 2008. View at Google Scholar
  73. L. Van Hoose, Y. Sawers, R. Loganathan et al., “Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat,” Cardiovascular Diabetology, vol. 9, p. 56, 2010. View at Google Scholar
  74. S. S. Chugh, K. Reinier, T. Singh et al., “Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon sudden unexpected death study,” Circulation, vol. 119, no. 5, pp. 663–670, 2009. View at Publisher · View at Google Scholar · View at PubMed
  75. R. Pop-Busui, P. A. Low, B. H. Waberski et al., “Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the diabetes control and complications trial/epidemiology of diabetes interventions and complications study (DCCT/EDIC),” Circulation, vol. 119, pp. 2886–2893, 2009. View at Google Scholar
  76. T. Laitinen, T. Lyyra-Laitinen, H. Huopio et al., “Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects,” Annals of Noninvasive Electrocardiology, vol. 13, no. 2, pp. 97–105, 2008. View at Publisher · View at Google Scholar · View at PubMed
  77. D. Ziegler, C. P. Zental, S. Perz et al., “Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort study,” Diabetes Care, vol. 31, no. 3, pp. 556–561, 2008. View at Publisher · View at Google Scholar · View at PubMed
  78. J. M. Pappachan, J. Sebastian, B. C. Bino et al., “Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis,” Postgraduate Medical Journal, vol. 84, no. 990, pp. 205–210, 2008. View at Publisher · View at Google Scholar · View at PubMed
  79. B. S. Rana, P. O. Lim, A. A. O. Naas et al., “QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests,” Heart, vol. 91, no. 1, pp. 44–50, 2005. View at Publisher · View at Google Scholar · View at PubMed
  80. G. Grossman, M. Schwentikowski, F. S. Keck et al., “Signal-averaged electrocardiogram in patients with insulin-dependent (type 1) diabetes mellitus with and without diabetic neuropathy,” Diabetic Medicine, vol. 14, pp. 364–369, 2004. View at Google Scholar
  81. M. R. Carnethon, S. H. Golden, A. R. Folsom, W. Haskell, and D. Liao, “Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study, 1987–1998,” Circulation, vol. 107, pp. 2190–2195, 2003. View at Google Scholar
  82. N. Tentolouris, N. Katsilambros, G. Papazachos et al., “Corrected QT interval in relation to the severity of diabetic autonomic neuropathy,” European Journal of Clinical Investigation, vol. 27, no. 12, pp. 1049–1054, 1997. View at Google Scholar
  83. D. J. Ewing, O. Boland, J. M. M. Neilson, C. G. Gho, and B. F. Clarke, “Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients,” Diabetologia, vol. 34, no. 3, pp. 182–185, 1991. View at Google Scholar
  84. J. A. Kors, M. C. De Bruyne, A. W. Hoes et al., “T axis as an indicator of risk of cardiac events in elderly people,” Lancet, vol. 352, no. 9128, pp. 601–605, 1998. View at Publisher · View at Google Scholar
  85. P. M. Rautaharju, J. C. Nelson, R. A. Kronmal et al., “Usefulness of T-axis deviation as an independent risk indicator for incident cardiac events in older men and women free from coronary heart disease (the Cardiovascular Health Study),” American College of Cardiology, vol. 88, no. 2, pp. 118–123, 2001. View at Google Scholar
  86. B. Triola, M. B. Olson, S. E. Reis et al., “Electrocardiographic predictors of cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored women's ischemia syndrome evaluation (WISE) study,” Journal of the American College of Cardiology, vol. 46, no. 1, pp. 51–56, 2005. View at Publisher · View at Google Scholar · View at PubMed
  87. American Academy of Neurology, “Assessment: clinical autonomic testing report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology,” Neurology, vol. 46, no. 3, pp. 873–880, 1996. View at Google Scholar
  88. A. Kassoff, R. A. Catalano, and M. Mehu, “Vitreous hemorrhage and the valsalva maneuver in proliferative diabetic retinopathy,” Retina, vol. 8, no. 3, pp. 174–175, 1988. View at Google Scholar
  89. M. Rosengård-Bärlund, L. Bernardi, J. Fagerudd et al., “Early autonomic dysfunction in type 1 diabetes: a reversible disorder?” Diabetologia, vol. 52, no. 6, pp. 1164–1172, 2009. View at Google Scholar
  90. J. Cabezas-Cerrato, A. Gonzalez-Quintela, M. Perez-Rodriguez et al., “Combination of cardiorespiratory reflex parameters and heart rate variability power spectrum analysis for early diagnosis of diabetic cardiac autonomic neuropathy,” Diabetes & Metabolism, vol. 35, no. 4, pp. 305–311, 2009. View at Google Scholar
  91. R. Freeman, “Assessment of cardiovascular autonomic function,” Clinical Neurophysiology, vol. 117, no. 4, pp. 716–730, 2006. View at Publisher · View at Google Scholar · View at PubMed
  92. P. Kempler, S. Tesfaye, N. Chaturvedi et al., “Blood pressure response to standing in the diagnosis of autonomic neuropathy: the EURODIAB IDDM Complications Study,” Archives of Physiology and Biochemistry, vol. 109, no. 3, pp. 215–222, 2001. View at Publisher · View at Google Scholar · View at PubMed
  93. R. Pop-Busui, W. H. Herman, E. L. Feldman et al., “DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history,” Current Diabetes Reports, vol. 10, no. 4, pp. 276–282, 2010. View at Publisher · View at Google Scholar · View at PubMed
  94. D. Hoyer, R. Maestri, M. Teresa La Rovere, and G. D. Pinna, “Autonomic response to cardiac dysfunction in chronic heart failure: a risk predictor based on autonomic information flow,” Pacing and Clinical Electrophysiology, vol. 31, no. 2, pp. 214–220, 2008. View at Publisher · View at Google Scholar · View at PubMed
  95. A. Ghuran, F. Reid, M. T. La Rovere et al., “Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy),” American Journal of Cardiology, vol. 89, no. 2, pp. 184–190, 2002. View at Google Scholar
  96. A. Heitmann, T. Huebner, R. Schroeder, S. Perz, and A. Voss, “Multivariate short-term heart rate variability: a pre-diagnostic tool for screening heart disease,” Medical and Biological Engineering and Computing, vol. 49, no. 1, pp. 41–50, 2011. View at Publisher · View at Google Scholar · View at PubMed
  97. C. Quattrini, M. Jeziorska, M. Tavakoli, P. Begum, A. J. M. Boulton, and R. A. Malik, “The Neuropad test: a visual indicator test for human diabetic neuropathy,” Diabetologia, vol. 51, no. 6, pp. 1046–1050, 2008. View at Publisher · View at Google Scholar · View at PubMed
  98. N. Tentolouris, V. Achtsidis, K. Marinou, and N. Katsilambros, “Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes,” Diabetes Care, vol. 31, no. 2, pp. 236–237, 2008. View at Publisher · View at Google Scholar · View at PubMed
  99. F. Lombardi, “Clinical implications of present physiological understanding of HRV components,” Cardiac Electrophysiology Review, vol. 6, no. 3, pp. 245–249, 2002. View at Publisher · View at Google Scholar
  100. C. Voulgari, M. Psallas, A. Kokkinos, V. Argiana, N. Katsilambros, and N. Tentolouris, “The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes,” Journal of Diabetes and Its Complications, vol. 25, no. 3, pp. 159–167, 2011. View at Google Scholar
  101. N. Tentolouris, S. Liatis, I. Moyssakis et al., “Aortic distensibility is reduced in subjects with type 2 diabetes and cardiac autonomic neuropathy,” European Journal of Clinical Investigation, vol. 33, no. 12, pp. 1075–1083, 2003. View at Publisher · View at Google Scholar
  102. K. Cruickshank, L. Riste, S. G. Anderson, J. S. Wright, G. Dunn, and R. G. Gosling, “Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?” Circulation, vol. 106, no. 16, pp. 2085–2090, 2002. View at Publisher · View at Google Scholar
  103. M. Veglio, A. Chinaglia, and P. Cavallo, “The clinical utility of QT interval assessment in diabetes,” Diabetes, Nutrition and Metabolism—Clinical and Experimental, vol. 13, no. 6, pp. 356–365, 2000. View at Google Scholar
  104. D. Aronson, L. A. Weinrauch, J. A. D'Elia, G. H. Tofler, and A. J. Burger, “Circadian patterns of heart rate variability, fibrinolytic activity, and hemostatic factors in type I diabetes mellitus with cardiac autonomic neuropathy,” American Journal of Cardiology, vol. 84, no. 4, pp. 449–453, 1999. View at Publisher · View at Google Scholar
  105. R. S. Bexton, H. O. Vallin, and A. J. Camm, “Diurnal variation of the QT interval—influence of the autonomic nervous system,” British Heart Journal, vol. 55, no. 3, pp. 253–258, 1986. View at Google Scholar
  106. P. E. Valensi, N. B. Johnson, P. Maison-Blanche, F. Extramania, G. Motte, and P. Coumel, “Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients,” Diabetes Care, vol. 25, no. 5, pp. 918–923, 2002. View at Publisher · View at Google Scholar
  107. J. J. C. Ong, J. S. M. Sarma, K. Venkataraman, S. R. Levin, and B. N. Singh, “Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death,” American Heart Journal, vol. 125, no. 3, pp. 744–752, 1993. View at Publisher · View at Google Scholar
  108. D. Kocovic, D. Velimirovic, M. Djordjevic, S. Pavlovic, D. Savic, and P. Stojanov, “Association between stimulated QT interval and ventricular rhythm disturbances influence of autonomic nervous system,” Pacing and Clinical Electrophysiology, vol. 11, no. 11, pp. 1722–1731, 1988. View at Google Scholar
  109. E. Z. Soliman, M. A. Elsalam, and Y. Li, “The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording,” Europace, vol. 12, no. 2, pp. 261–265, 2010. View at Publisher · View at Google Scholar · View at PubMed
  110. T. G. Farrell, Y. Bashir, T. Cripps et al., “Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and signal-averaged electrocardiogram,” Journal of the American College of Cardiology, vol. 18, no. 3, pp. 687–697, 1991. View at Google Scholar
  111. S. Tamaki, T. Yamada, Y. Okuyama et al., “Cardiac Iodine-123 Metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction. Results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion,” Journal of the American College of Cardiology, vol. 53, no. 5, pp. 426–435, 2009. View at Publisher · View at Google Scholar · View at PubMed
  112. M. A. Kowalewski, M. Urban, B. Florys, and J. Peczynska, “Late potentials—are they related to cardiovascular complications in children with type 1 diabetes?” Journal of Diabetes and Its Complications, vol. 16, no. 4, pp. 263–270, 2002. View at Publisher · View at Google Scholar
  113. A. Van Oosterom, “Reflections on T waves,” in Advances in Electrocardiology, M. Hiraoka, S. Ogawa, I. Kodam, M. Inoue, H. Kasanuki, and T. Katoh, Eds., pp. 807–815, World Scientific, Singapore, 2005. View at Google Scholar
  114. P. Sahu, P. O. Lim, B. S. Rana, and A. D. Struthers, “QT dispersion in medicine: electrophysiological Holy Grail or fool's gold?” QJM, vol. 93, no. 7, pp. 425–431, 2000. View at Google Scholar
  115. S. Luo, K. Michler, P. Johnston, and P. W. MacFarlane, “A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs,” Journal of Electrocardiology, vol. 37, supplement, pp. 81–90, 2004. View at Publisher · View at Google Scholar
  116. B. Bravenboer, P. H. Hendriksen, L. P. Oey, W. H. Gispen, A. C. Van Huffelen, and D. W. Erkelens, “Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy?” Diabetes Care, vol. 16, no. 9, pp. 1249–1253, 1993. View at Google Scholar
  117. M. Psallas, N. Tentolouris, A. Cokkinos, D. Papadogiannis, D. V. Cokkinos, and N. Katsilambros, “QT dispersion: comparison between diabetic and non-diabetic individuals and correlation with cardiac autonomic neuropathy,” Hellenic Journal of Cardiology, vol. 47, no. 5, pp. 255–262, 2006. View at Google Scholar
  118. C. Voulgari, I. Moyssakis, D. Perrea, D. Kyriaki, N. Katsilambros, and N. Tentolouris, “The association between the spatial QRS-T angle with cardiac autonomic neuropathy in subjects with Type 2 diabetes mellitus,” Diabetic Medicine, vol. 27, no. 12, pp. 1420–1429, 2010. View at Google Scholar
  119. V. Batchvarov, J. C. Kaski, N. Parchure et al., “Comparison between ventricular gradient and a new descriptor of the wavefront direction of ventricular activation and recovery,” Clinical Cardiology, vol. 25, no. 5, pp. 230–236, 2002. View at Google Scholar
  120. L. Edenbrandt, A. Jakobsson, E. Lindvall, P. O. Bitzén, and O. Pahlm, “Increased prevalence of large bites in 12-lead vectorcardiograms of diabetic patients,” Journal of Electrocardiology, vol. 30, no. 2, pp. 91–95, 1997. View at Google Scholar · View at Scopus
  121. O. Casis and E. Echevarria, “Diabetic cardiomyopathy: electromechanical cellular alterations,” Current Vascular Pharmacology, vol. 2, no. 3, pp. 237–248, 2004. View at Publisher · View at Google Scholar · View at Scopus
  122. N. Niwa and J. M. Nerbonne, “Molecular determinants of cardiac transient outward potassium current (I) expression and regulation,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 1, pp. 12–25, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  123. G. E. Billman, “Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training,” American Journal of Physiology, vol. 297, no. 4, pp. H1171–H1193, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  124. M. Kim, J. K. Oh, S. Sakata et al., “Role of resistin in cardiac contractility and hypertrophy,” Journal of Molecular and Cellular Cardiology, vol. 45, no. 2, pp. 270–280, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus